Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)

Dirk Von Lewinski

Graz, AT 
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Graz, AT 
OverviewLocationsClinical Research

Overview

Dirk Von Lewinski practices in Graz, Austria. Mr. Von Lewinski is rated as a Distinguished expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure, Heart Attack, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiogenic Shock, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 144 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Graz, Austria
Other Locations
Schwarzach Im Pongau, 5620, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effect of Transfemoral Transcatheter Aortic Valve Replacement (TF-TAVR) on Emotional Status, Quality of Life, Frailty and Inflammation and Their Interactions
Effect of Transfemoral Transcatheter Aortic Valve Replacement (TF-TAVR) on Emotional Status, Quality of Life, Frailty and Inflammation and Their Interactions
Enrollment Status: Terminated
Publish Date: January 11, 2023
Intervention Type: Diagnostic test
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

144 Total Publications

Atrial fibrillation in end-stage heart failure: Cellular mechanisms behind CASTLE-HTx.
Atrial fibrillation in end-stage heart failure: Cellular mechanisms behind CASTLE-HTx.
Journal: European journal of heart failure
Published: August 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Von Lewinski's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile